Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Cash Flow Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Operating Activities
Net Income (Quarter)	-10.35M	-12.95M	-12.70M	-14.66M	-16.07M	-17.50M	-19.41M	-22.84M	-21.47M	-25.71M	-30.14M	-28.52M	-31.50M	-34.13M	-39.66M	-40.80M	-36.12M	-40.67M	-50.22M	-49.01M
Depreciation and Depletion (Quarter)	0.05M	0.10M	0.07M	0.10M	0.10M	0.10M	0.12M	0.20M	0.40M	0.40M	0.48M	0.50M	0.50M	0.50M	0.60M	0.51M	0.50M	0.50M	0.54M	0.54M
Share-based Compensation (Quarter)	0.69M	1.55M	1.87M	1.98M	2.04M	3.17M	3.74M	3.84M	4.01M	4.56M	5.15M	4.87M	5.22M	6.88M	7.74M	9.06M	7.73M	8.09M	9.88M	8.71M
Gains from Sales and Divestitures (Quarter)											0.09M				0.08M				0.21M
Gains from Investment Securities (Quarter)	0.09M	1.53M	7.59M	2.17M	0.34M	2.95M		1.12M	1.53M	5.04M		5.04M	1.53M	0.56M	15.42M	5.04M	2.00M	5.04M	1.01M	0.69M
Non-cash Items (Quarter)			76.60M				13.40M	1.53M	1.53M	1.53M	6.85M	1.53M	1.53M	1.46M	4.60M	1.35M	1.35M	1.25M		1.15M
Cash from Operations (Quarter)	-9.77M	-8.26M	-9.42M	-12.57M	-16.25M	-11.96M	-11.86M	-22.83M	-20.23M	-22.06M	-26.83M	-28.60M	-26.10M	-27.37M	-26.96M	-37.87M	-32.58M	-34.78M	-38.59M	-42.54M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)				-0.67M	0.77M	-1.31M	1.38M	2.08M	-1.99M	7.26M	2.17M	0.05M	6.65M	3.24M	2.60M	1.92M	2.20M	-3.99M	0.05M	0.05M
Depreciation & Amortization (CF) (Quarter)	0.05M	0.10M	0.07M	0.10M	0.10M	0.10M	0.12M	0.20M	0.40M	0.40M	0.48M	0.50M	0.50M	0.50M	0.60M	0.51M	0.50M	0.50M	0.54M	0.54M
Change in Working Capital
Change in Account Payables (Quarter)	1.69M	-0.52M	1.55M	1.19M	-2.65M	0.94M	0.58M	-0.16M	-0.31M	1.76M	-1.38M	0.78M	1.89M	-1.03M	0.09M	2.86M	-0.15M	-2.13M	-0.30M	1.45M
Change in Accured Expenses (Quarter)	1.92M	-0.56M	0.77M	-0.85M	1.09M	-0.43M	1.43M	-1.96M	1.05M	1.04M	1.53M	-0.10M	-1.35M	1.94M	0.67M	0.12M	-1.42M	-0.77M	4.43M	0.64M
Investing Activities
Capital Expenditures (Quarter)	0.08M	0.45M	0.08M	0.31M	0.14M	2.13M	-0.07M	4.37M	0.76M	0.46M	0.16M	0.14M	-0.03M	0.09M	-0.16M	0.04M	0.05M	-0.05M	0.21M	0.04M
Change in Acquisitions & Divestments (Quarter)		10.20M	25.80M	36.88M	59.77M	30.28M	69.86M	69.76M	114.12M	94.50M	-258.26M	58.71M	77.67M	-123.66M	3.07M	151.12M	78.00M	-177.67M	375.86M	3.97M
Cash from Investing Activities (Quarter)	-159.97M	-31.61M	14.12M	31.39M	-0.05M	-26.32M	-75.60M	49.04M	3.44M	23.42M	26.98M	-268.31M	37.37M	25.36M	20.92M	43.90M	-162.17M	35.72M	49.76M	2.43M
Financing Activities
Other financing activities (Quarter)						0.08M	-0.09M		0.03M		-0.10M		1.58M	0.21M	9.22M	0.04M	0.23M	1.66M	5.87M
Change in Capital Stock
Shares Issued (Quarter)	186.12M		-186.04M	0.07M	0.10M	129.54M	-129.31M	0.02M	0.32M	-0.28M	0.54M	239.15M	-235.64M	-3.08M	0.47M	2.26M	-1.66M	186.76M	-179.56M	12.17M
Preferred Shares Issued (Quarter)
Misc.
Cash from Financing Activities (Quarter)	-0.90M	0.04M	0.29M	0.07M	0.18M	129.69M	-0.30M	0.02M	0.37M	-0.21M	52.99M	241.07M	1.95M	3.33M	2.90M	2.22M	188.23M	1.66M	3.98M	12.17M
Change in Cash (Quarter)	-170.63M	-39.83M	5.00M	18.89M	-16.11M	91.41M	-87.75M	26.24M	-16.42M	1.15M	53.14M	-55.83M	13.22M	1.32M	-3.14M	8.26M	-6.52M	2.60M	15.14M	-27.94M
Free Cash Flow (Quarter)	-9.85M	-8.71M	-9.50M	-12.88M	-16.39M	-14.09M	-11.79M	-27.19M	-20.99M	-22.52M	-26.99M	-28.74M	-26.07M	-27.46M	-26.80M	-37.91M	-32.63M	-34.73M	-38.80M	-42.58M
Net Cash Flow (Quarter)	-170.63M	-39.83M	5.00M	18.89M	-16.11M	91.41M	-87.75M	26.24M	-16.42M	1.15M	53.14M	-55.83M	13.22M	1.32M	-3.14M	8.26M	-6.52M	2.60M	15.14M	-27.94M

Research Tools

Developers

Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Research Tools

Developers

Edgewise Therapeutics Cash Flow Statement (2020-2026) | EWTX

Create an account

Sign In

Reset Password